Adherence to aspirin use during pregnancy among women at risk of preeclampsia: A cross‐sectional study
Acta Obstetricia et Gynecologica Scandinavica · 2026-09 · 105 (9) · 1778-1788
DOI: 10.1111/aogs.70281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 11.06.2026. Verfasst von Emma M Swift und 9 weiteren Autor:innen. Beteiligte Einrichtung: Reykjavik Birth Center, Reykjavik, Iceland. Hauptthemen laut MEDLINE: Aspirin, Pre-Eclampsia, Platelet Aggregation Inhibitors, Drug Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Science Fund of Landspítali.
Abstract (Originalsprache)
Introduction Aspirin prevents severe preeclampsia, but its effectiveness depends on its use. Aspirin is recommended in pregnancy for women at risk of preeclampsia. However, evidence on prophylactic aspirin uptake and adherence is limited. The aim was to examine whether women at risk received recommendations to use aspirin and estimate the prevalence of inadequate adherence. Material and Methods Cross‐sectional internet survey conducted in Iceland. Pregnancies were classified as low, moderate, and high risk for preeclampsia according to guidelines. The Morisky‐Medicine‐Adherence‐Scale© (MMAS‐8) was used to estimate adherence, classified as good (8 points), moderate (6–7.9), and inadequate (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reykjavik Birth Center, Reykjavik, Iceland.
- Faculty of Nursing and Midwifery, University of Iceland, Reykjavik, Iceland.
- Populus Statistics, Hafnarfjordur, Iceland.
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- Department of Obstetrics and Gynecology, Landspitali - The University Hospital of Iceland, Reykjavik, Iceland.
- Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland.
ORCID-Profile: Emma M Swift, Sigurbjörg A Guðnadóttir, Eygló H Haraldsdóttir, Hulda Hjartardóttir, Lilja Ó Atladóttir, Helga Helgadóttir, Lárus S Guðmundsson, Rannveig Sigurvinsdóttir, Kristjana H Ásbjörnsdóttir, Jóhanna Gunnarsdóttir
Förderung
- The Science Fund of Landspítali
Zitieren
APA
Swift, E. M., Guðnadóttir, S. A., Haraldsdóttir, E. H., Hjartardóttir, H., Atladóttir, L. Ó., Helgadóttir, H., Guðmundsson, L. S., Sigurvinsdóttir, R., Ásbjörnsdóttir, K. H., & Gunnarsdóttir, J. (2026). Adherence to aspirin use during pregnancy among women at risk of preeclampsia: A cross‐sectional study. Acta Obstetricia et Gynecologica Scandinavica, 105(9), 1778-1788. https://doi.org/10.1111/aogs.70281
Vancouver
Swift EM, Guðnadóttir SA, Haraldsdóttir EH, Hjartardóttir H, Atladóttir LÓ, Helgadóttir H, et al. Adherence to aspirin use during pregnancy among women at risk of preeclampsia: A cross‐sectional study. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(9):1778-1788. doi:10.1111/aogs.70281
BibTeX
@article{Swift2026,
author = {Swift, Emma M and Guðnadóttir, Sigurbjörg A and Haraldsdóttir, Eygló H and Hjartardóttir, Hulda and Atladóttir, Lilja Ó and Helgadóttir, Helga and Guðmundsson, Lárus S and Sigurvinsdóttir, Rannveig and Ásbjörnsdóttir, Kristjana H and Gunnarsdóttir, Jóhanna},
title = {Adherence to aspirin use during pregnancy among women at risk of preeclampsia: A cross‐sectional study},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2026},
volume = {105},
number = {9},
pages = {1778--1788},
doi = {10.1111/aogs.70281}
}
EUVIMED